Stockscreener 앱 받기
0.5704
4.09%
-0.0243
시간 외 거래:
.60
0.0296
+5.19%
Biodesix Inc 주식(BDSX)의 최신 뉴스
Biodesix, Inc. (NASDAQ:BDSX) Short Interest Update - MarketBeat
HighTower Advisors LLC Acquires 22,500 Shares of Biodesix, Inc. (NASDAQ:BDSX) - Defense World
AIGH Capital Management LLC Buys 500,000 Shares of Biodesix, Inc. (NASDAQ:BDSX) - MarketBeat
12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga
Perkins Capital Management Inc. Purchases 335,429 Shares of Biodesix, Inc. (NASDAQ:BDSX) - MarketBeat
12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga
Biodesix Completes Enrollment of INSIGHT Study Assessing Clinical Utility of the VeriStrat® Blood-Based Host Immune Classifier - Business Wire
Biodesix, Inc. (NASDAQ:BDSX) Short Interest Up 24.6% in February - Defense World
Biodesix to Present at Cowen’s 42nd Annual Healthcare Conference - Business Wire
Biodesix chief commercial officer sells shares worth $16,198 - MSN
Q1 Earnings Estimate for Biodesix Issued By William Blair - MarketBeat
Biodesix's (BDSX) "Outperform" Rating Reaffirmed at William Blair - MarketBeat
Biodesix (NASDAQ:BDSX) Issues Quarterly Earnings Results - MarketBeat
Q1 Earnings Forecast for Biodesix Issued By William Blair - Defense World
Biodesix (BDSX) Upgraded to Buy: What Does It Mean for the Stock? - MSN
Biodesix improved sales, cut losses in fourth quarter, fiscal 2024 - BizWest
Biodesix at TD Cowen Conference: Transformative Year Ahead By Investing.com - Investing.com UK
Biodesix at TD Cowen Conference: Transformative Year Ahead - Investing.com
Analysts Have Been Trimming Their Biodesix, Inc. (NASDAQ:BDSX) Price Target After Its Latest Report - Yahoo Finance
William Blair Estimates Biodesix’s Q1 Earnings (NASDAQ:BDSX) - Defense World
It's Down 30% But Biodesix, Inc. (NASDAQ:BDSX) Could Be Riskier Than It Looks - Simply Wall St
Biodesix (NASDAQ:BDSX) Receives “Outperform” Rating from William Blair - Defense World
Biodesix, Inc. Reports Strong Growth Amid Financial Challenges - TipRanks
Positive Outlook for Biodesix: Buy Rating Supported by Salesforce Improvements and Revenue Growth Opportunities - TipRanks
Earnings call transcript: Biodesix Q4 2024 beats revenue expectations By Investing.com - Investing.com South Africa
Observations on the Biodesix Inc (NASDAQ:BDSX) Growth Curve - US Post News
Biodesix, Inc. (NASDAQ:BDSX) Q4 2024 Earnings Call Transcript - MSN
Biodesix: Strong Growth and Promising Future with Buy Rating from Kyle Mikson CFA - TipRanks
US Futures Tumble As Traders Await Trump's Congress Address: 'Volatility Is Certainly Being Fed By Trump 2.0 Moves,' Says ExpertCrowdStrike Holdings (NASDAQ:CRWD), Biodesix (NASDAQ:BDSX) - Benzinga
Biodesix, Inc. (BDSX): Among Penny Stocks with Insider Buying in 2025 - Insider Monkey
12 Penny Stocks with Insider Buying in 2025 - Insider Monkey
Biodesix Inc (BDSX) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ... - Yahoo Finance
Biodesix Inc (BDSX) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ... By GuruFocus - Investing.com Canada
Biodesix Reports Strong 2024 Financial Performance - TipRanks
Biodesix Inc reports results for the quarter ended December 31Earnings Summary - TradingView
BIODESIX Earnings Results: $BDSX Reports Quarterly Earnings - Nasdaq
Earnings call transcript: Biodesix Q4 2024 beats revenue expectations - Investing.com
Biodesix earnings beat by $0.01, revenue topped estimates - Investing.com Canada
Earnings Flash (BDSX) BIODESIX INC. Reports Q4 Revenue $20.4M, vs. FactSet Est of $19.9M - Marketscreener.com
Biodesix Announces Fourth Quarter and Fiscal Year 2024 Results - GlobeNewswire
Biodesix chief accounting officer Chris Vazquez sells $3,354 in stock - MSN
Biodesix (BDSX) Expected to Announce Quarterly Earnings on Monday - Defense World
Biodesix Inc expected to post a loss of 7 cents a shareEarnings Preview - TradingView
3.49%
자본화:
|
볼륨(24시간):